125 related articles for article (PubMed ID: 8979005)
21. Angiotensin I converting enzyme gene polymorphism and reflux nephropathy in children.
Gallego N; Estepa R; Tellería D; San Millán JL; Belanger A; Ortuño J
Nephron; 2001 Oct; 89(2):231-2. PubMed ID: 11549909
[No Abstract] [Full Text] [Related]
22. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
23. [Gene polymorphisms of renin-angiotensin system in patients with kidney diseases].
Narita I; Gejyo F
Nihon Rinsho; 2004 Oct; 62(10):1811-5. PubMed ID: 15500123
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme gene I/D polymorphism and renal disease.
Navis G; van der Kleij FG; de Zeeuw D; de Jong PE
J Mol Med (Berl); 1999 Nov; 77(11):781-91. PubMed ID: 10619438
[TBL] [Abstract][Full Text] [Related]
25. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk.
Staessen JA; Wang JG; Ginocchio G; Petrov V; Saavedra AP; Soubrier F; Vlietinck R; Fagard R
J Hypertens; 1997 Dec; 15(12 Pt 2):1579-92. PubMed ID: 9488209
[TBL] [Abstract][Full Text] [Related]
26. Progression of atherosclerosis in patients with peripheral arterial disease as a function of angiotensin-converting enzyme gene insertion/deletion polymorphism.
Taute BM; Gläser C; Taute R; Podhaisky H
Angiology; 2002; 53(4):375-82. PubMed ID: 12143941
[TBL] [Abstract][Full Text] [Related]
27. The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases.
McLaughlin KJ; Harden PN; Ueda S; Boulton-Jones JM; Connell JM; Jardine AG
Hypertension; 1996 Nov; 28(5):912-5. PubMed ID: 8901844
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme polymorphism in patients with terminal renal failure.
Schmidt A; Kiener HP; Barnas U; Arias I; Illievich A; Auinger M; Graninger W; Kaider A; Mayer G
J Am Soc Nephrol; 1996 Feb; 7(2):314-7. PubMed ID: 8785402
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
Zhou TB; Yin SS; Liang R
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
[TBL] [Abstract][Full Text] [Related]
30. Potential risk factors associated with progressive renal damage in childhood urological diseases: the role of angiotensin-converting enzyme gene polymorphism.
Brock JW; Adams M; Hunley T; Wada A; Trusler L; Kon V
J Urol; 1997 Sep; 158(3 Pt 2):1308-11. PubMed ID: 9258202
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
[TBL] [Abstract][Full Text] [Related]
32. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor.
Li X; Du Y; Du Y; Huang X
J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):25-30. PubMed ID: 12652327
[TBL] [Abstract][Full Text] [Related]
33. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.
Narita I; Goto S; Saito N; Song J; Ajiro J; Sato F; Saga D; Kondo D; Akazawa K; Sakatsume M; Gejyo F
Hypertension; 2003 Sep; 42(3):304-9. PubMed ID: 12885793
[TBL] [Abstract][Full Text] [Related]
34. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin I-converting enzyme insertion/deletion polymorphism: clinical implications.
Wuyts B; Delanghe J; De Buyzere M
Acta Clin Belg; 1997; 52(6):338-49. PubMed ID: 9489129
[TBL] [Abstract][Full Text] [Related]
36. Association of angiotensin I converting enzyme gene polymorphism with reflux nephropathy in children.
Park HW; Koo JW; Kim JS; Ha IS; Cheong HI; Choi Y
Nephron; 2000 Sep; 86(1):52-5. PubMed ID: 10971153
[TBL] [Abstract][Full Text] [Related]
37. ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.
Ha SK
J Diabetes Res; 2014; 2014():846068. PubMed ID: 25587546
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival.
Beige J; Offermann G; Distler A; Sharma AM
Nephrol Dial Transplant; 1998 Mar; 13(3):735-8. PubMed ID: 9550656
[TBL] [Abstract][Full Text] [Related]
39. Role of angiotensin-converting enzyme gene polymorphism in progressive loss of renal function in chronic renal diseases.
Yoshida H; Ichikawa I; Sakai O
Contrib Nephrol; 1996; 118():249-53. PubMed ID: 8744065
[No Abstract] [Full Text] [Related]
40. [Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type II exist?].
Strojek K; Grzeszczak W; Rudzki H; Pokrzywnicki W; Lacka B; Schmidt S; Ritz E
Pol Arch Med Wewn; 1995 Sep; 94(3):214-8. PubMed ID: 8596758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
